Chris Schoenherr

Title: Chris Schoenherr: Innovator in Nuclease-Mediated DNA Assembly

Introduction

Chris Schoenherr is a notable inventor based in Piermont, NY (US). He has made significant contributions to the field of biotechnology, particularly in the area of DNA assembly. With a total of 5 patents to his name, Schoenherr's work has the potential to advance genetic engineering and molecular biology.

Latest Patents

One of Schoenherr's latest patents focuses on nuclease-mediated DNA assembly. This innovative method involves assembling at least two nucleic acids using a sequence-specific nuclease agent, such as a gRNA-Cas complex. The process creates end sequences that exhibit complementarity, allowing for the assembly of overlapping complementary sequences. The nuclease agent can induce double-strand breaks in dsDNA to generate overlapping end sequences or create nicks on each strand to produce complementary overhanging end sequences. This method can assemble any nucleic acids with overlapping sequences or utilize a joiner oligo to connect sequences without complementary ends.

Career Highlights

Chris Schoenherr is currently employed at Regeneron Pharmaceuticals, Inc., where he continues to innovate in the field of biotechnology. His work has garnered attention for its potential applications in genetic research and therapeutic development.

Collaborations

Schoenherr collaborates with talented individuals such as John R McWhirter and Corey Momont, contributing to a dynamic research environment that fosters innovation.

Conclusion

Chris Schoenherr's contributions to nuclease-mediated DNA assembly exemplify the impact of innovative thinking in biotechnology. His patents and ongoing work at Regeneron Pharmaceuticals, Inc. highlight the importance of collaboration and creativity in advancing scientific knowledge.